Journal Article Summary
The article investigates how obesity affects the pharmacokinetics of oseltamivir, an antiviral medication used to treat influenza. This topic is important because obesity has been linked to worse outcomes in patients with influenza, particularly during the H1N1 pandemic. There has been concern about whether standard dosing of oseltamivir is adequate for obese patients, leading to suggestions that higher doses might be necessary.
The study involved 21 healthy adult volunteers with severe obesity (class III, BMI ≥ 40 kg/m²) who received a standard dose of oseltamivir (75 mg twice daily). Researchers measured how the drug and its active form, oseltamivir carboxylate, were processed in the body. They found that the levels of oseltamivir carboxylate in obese individuals were similar to those in non-obese adults, indicating that the standard dosing is effective for this population. Although body size did influence the clearance of the drug, the effect was weak, suggesting that higher doses are not needed for obese patients.
Despite the findings, the study has limitations, including a small sample size and the fact that it only included healthy volunteers, which may not represent all obese patients. Patients should be aware that while standard doses of oseltamivir appear to be sufficient for those with class III obesity, individual health factors can vary. It is advisable for patients to discuss their specific circumstances and any concerns about medication dosing with their healthcare provider to ensure safe and effective treatment.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Pai Manjunath P., Lodise Thomas P.. Oseltamivir and Oseltamivir Carboxylate Pharmacokinetics in Obese Adults: Dose Modification for Weight Is Not Necessary ▿ †. Antimicrobial Agents and Chemotherapy 2011. DOI: 10.1128/AAC.00422-11. PMID: 21930881. PMCID: PMC3232799.
Featured Pill Pals Product
Oseltamivir Phosphate 6 mg / ml Oral Suspension --- Generic For Tamiflu (60 ml Total) --- Ajanta Pharma
Oseltamivir Phosphate 6 mg / ml Oral Suspension --- Generic For Tamiflu (60 ml Total) --- Ajanta Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
